HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Renlund, N. Articles by Teixeira, J. Search for Related Content PubMed PubMed Citation Articles by Renlund, N. Articles by Teixeira, J.

Vincent Center for Reproductive Biology, Massachusetts General Hospital and Harvard Medical School, Thier 913, 55 Fruit Street, Boston, Massachusetts 02114, USA
¹ Pediatric Surgical Research Laboratories and
² Reproductive Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA

(Correspondence should be addressed to J Teixeira; Email: teixeira{at}helix.mgh.harvard.edu)

Activin receptor-like kinase-2 (Alk2) has been shown to be a promiscuous type I receptor for the transforming growth factor ß (TGFß) family of growth and differentiation factors, such as activin, bone morphogenetic proteins, and Müllerian inhibiting substance (MIS). We have studied the putative role of Alk2 in activin signaling using MA-10 cells, a mouse transformed Leydig cell line, in which endogenous expression of cytochrome P450 c17 hydroxylase/C17–20 lyase mRNA is inhibited by both MIS and activin A. Overexpression of Alk2 in MA-10 cells inhibited the activation of the activin-responsive CAGA-luciferase reporter and, conversely, transfection of siRNA for Alk2 increased the response. In contrast, overexpression of the MIS type II receptor in MA-10 cells increased the activin-mediated induction of CAGA-luciferase approximately fivefold, which we hypothesized occurs by MIS type II receptor sequestering endogenous Alk2. Binding experiments with ¹²⁵I-labeled activin show that the underlying mechanism of Alk2-mediated inhibition of activin signaling involves Alk2 blocking the access of activin to its type II receptor, which we show can bind Alk2 in the absence of ligand. These results show that the complement of other type I receptors in addition to the ligand-specific type I receptor can provide an important mechanism for modulating cell-specific responses to members of the TGFß family.

This article has been cited by other articles:

				P. S. Tanwar, T. Kaneko-Tarui, L. Zhang, P. Rani, M. M. Taketo, and J. Teixeira Constitutive WNT/Beta-Catenin Signaling in Murine Sertoli Cells Disrupts Their Differentiation and Ability to Support Spermatogenesis Biol Reprod, February 1, 2010; 82(2): 422 - 432. [Abstract] [Full Text] [PDF]

				C. A. VandeVoort, N. R. Mtango, Y. S. Lee, G. W. Smith, and K. E. Latham Differential Effects of Follistatin on Nonhuman Primate Oocyte Maturation and Pre-Implantation Embryo Development In Vitro Biol Reprod, December 1, 2009; 81(6): 1139 - 1146. [Abstract] [Full Text] [PDF]